Compare MDXH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXH | TKNO |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 138.1M |
| IPO Year | 2021 | 2021 |
| Metric | MDXH | TKNO |
|---|---|---|
| Price | $0.98 | $3.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 147.5K | 89.9K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $30.78 | $8.27 |
| Revenue Next Year | $18.31 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $1.82 | $1.91 |
| 52 Week High | $5.33 | $6.86 |
| Indicator | MDXH | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 14.78 | 57.80 |
| Support Level | N/A | $3.60 |
| Resistance Level | $2.30 | $4.37 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 3.10 | 45.77 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.